Kip Publishes on Postoperative Infliximab and Crohn’s Disease

Regueiro, M., El-Hachem, S., Kip, K.E., Schraut, W., Baidoo, L., Watson, A., Swoger, J., Schwartz, M., Barrie, A., Pesci, M., & Binion, D. (2011). Postoperative Infliximab Is not associated with an increase in adverse events in Crohn’s disease. Digestive Diseases and Sciences 2011; Jun 17. [Epub ahead of print]